Reports for METHYLPHENIDATE HYDROCHLORIDE
Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-01 | 2024-03-22 | 221096 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65990 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-05-09 | 223862 |
| ACT METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65993 |
| ACT METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65996 |
| ACT METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65999 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2021-11-29 | 2021-12-17 | 150147 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-01-11 | 2022-02-26 | 152465 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-03-21 | 2022-05-04 | 157052 |
| FOQUEST | 45MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-05-20 | 2022-06-01 | 161057 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHYLPHENIDATE | 20MG | TABLET | Discontinued | 2019-04-10 | 2019-04-11 | 81139 |